Pipenzolate bromide

Pipenzolate bromide
Clinical data
ATC code	A03AB14 (WHO) ;
Identifiers
	IUPAC name 1-Ethyl-3-[2-hydroxy(diphenyl)acetoxy]-1-methylpiperidinium bromide;
CAS Number	125-51-9 ;
PubChem CID	657306;
ChemSpider	571430 ;
UNII	JPX41DUS2B;
ChEMBL	ChEMBL1401367 ;
CompTox Dashboard (EPA)	DTXSID2023480 ;
ECHA InfoCard	100.004.311
Chemical and physical data
Formula	C22H28BrNO3
Molar mass	434.374 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC[N+]1(CCCC(C1)OC(=O)C(c2ccccc2)(c3ccccc3)O)C.[Br-];
	InChI InChI=1S/C22H28NO3.BrH/c1-3-23(2)16-10-15-20(17-23)26-21(24)22(25,18-11-6-4-7-12-18)19-13-8-5-9-14-19;/h4-9,11-14,20,25H,3,10,15-17H2,1-2H3;1H/q+1;/p-1 ; Key:XEDCWWFPZMHXCM-UHFFFAOYSA-M ;
	(what is this?) (verify)

Pipenzolate bromide is a pharmaceutical drug that has been studied as an antispasmodic agent and to treat peptic ulcer.^[1]

Mechanism of action

Pipenzolate bromide acts as an antimuscarinic agent. It binds to muscarinic acetylcholine receptors as an antagonist therefore preventing acetylcholine from binding to the receptors.^[1]

^ ^a ^b "Pipenzolate". Inxight Drugs. National Center for Advancing Translational Sciences.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.